Heilongjiang ZBD Pharmaceutical Co Ltd Strategic Asset Allocation Index
Heilongjiang ZBD Pharmaceutical Co Ltd strategic asset allocation index. Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has a Strategic Asset Allocation Index of 19.6% as of June 2023. Strategic assets (PP&E of CN¥1.46 Billion plus long-term investments of CN¥-) total CN¥1.46 Billion, measured against net assets of CN¥7.44 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Heilongjiang ZBD Pharmaceutical Co Ltd's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Heilongjiang ZBD Pharmaceutical Co Ltd (2012–2021)
Strategic asset allocation index of Heilongjiang ZBD Pharmaceutical Co Ltd from 2012 to 2021. This chart shows how Heilongjiang ZBD Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 10 annual periods from 2012 to 2021. As of June 2023, the index stands at 19.6%, representing strategic assets of CN¥1.46 Billion against net assets of CN¥7.44 Billion CNY. Check tangible net worth ratio of Heilongjiang ZBD Pharmaceutical Co Ltd to evaluate the tangible quality of the company's equity base.
Heilongjiang ZBD Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2012–2021)
Heilongjiang ZBD Pharmaceutical Co Ltd strategic asset allocation index by year from 2012 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Heilongjiang ZBD Pharmaceutical Co Ltd from 2012 to 2021, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 603567 market cap.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 20.6% | CN¥1.45 Billion | CN¥1.45 Billion | CN¥- | CN¥7.05 Billion | ▼ -5.9 pp |
| 2020 | 26.5% | CN¥1.46 Billion | CN¥1.46 Billion | CN¥- | CN¥5.50 Billion | ▼ -3.0 pp |
| 2019 | 29.5% | CN¥1.55 Billion | CN¥1.55 Billion | CN¥- | CN¥5.25 Billion | ▼ -20.7 pp |
| 2018 | 50.2% | CN¥2.50 Billion | CN¥2.44 Billion | CN¥60.65 Million | CN¥4.98 Billion | ▲ +8.6 pp |
| 2017 | 41.6% | CN¥1.95 Billion | CN¥1.89 Billion | CN¥60.00 Million | CN¥4.68 Billion | ▲ +9.0 pp |
| 2016 | 32.6% | CN¥1.40 Billion | CN¥1.34 Billion | CN¥60.00 Million | CN¥4.31 Billion | ▼ -2.0 pp |
| 2015 | 34.6% | CN¥1.38 Billion | CN¥1.32 Billion | CN¥61.00 Million | CN¥3.98 Billion | ▼ -27.4 pp |
| 2014 | 62.0% | CN¥1.35 Billion | CN¥1.35 Billion | CN¥- | CN¥2.17 Billion | ▼ -3.3 pp |
| 2013 | 65.3% | CN¥1.14 Billion | CN¥1.14 Billion | CN¥- | CN¥1.75 Billion | ▼ -0.7 pp |
| 2012 | 66.0% | CN¥871.32 Million | CN¥871.32 Million | CN¥- | CN¥1.32 Billion | — |